| Warr Acres Nursing Center | |
| 6501 North Macarthur, Oklahoma City, Oklahoma 73132 | |
| (405) 721-5444 | |
| Name | Warr Acres Nursing Center |
|---|---|
| Location | 6501 North Macarthur, Oklahoma City, Oklahoma |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 103 |
| Occupancy Rate | 50.68% |
| Medicare ID (CCN) | 375275 |
| Legal Business Name | Warr Acres Operating Llc |
| Ownership Type | For Profit - Individual |
| NPI Number | 1407923824 |
| Organization Name | WARR ACRES NURSING CENTER, LLC |
| Address | 6501 N Macarthur Blvd, Oklahoma City, OK 73132 |
| Phone Number | 405-721-5444 |
News Archive
UK scientists have developed a peptide that sticks to the protein that causes Parkinson's disease, stopping it from killing brain cells. The research highlights a potential new route for slowing the progress of this incurable disease.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Kai Ruggeri's research has one overriding objective: to improve the well-being of populations by confronting inequality.
In the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Janet Fleischman and Julia Nagel of CSIS discuss "the opportunities and challenges of integrating cervical cancer screening and treatment into HIV services for women," with a focus on the efforts of Zambia.
A recent study published on the preprint server bioRxiv* in September 2020 looked to see if biting insects pose a risk for transmission of SARS-CoV-2 to humans or animals following a SARS-CoV-2 infected blood meal.
› Verified 5 days ago
| NPI Number | 1568951093 |
| Organization Name | N & R OF WARR ACRES LLC |
| Doing Business As | WARR ACRES NURSING CENTER |
| Address | 6501 N Macarthur Blvd, Oklahoma City, OK 73132 |
| Phone Number | 405-721-5444 |
News Archive
UK scientists have developed a peptide that sticks to the protein that causes Parkinson's disease, stopping it from killing brain cells. The research highlights a potential new route for slowing the progress of this incurable disease.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Kai Ruggeri's research has one overriding objective: to improve the well-being of populations by confronting inequality.
In the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Janet Fleischman and Julia Nagel of CSIS discuss "the opportunities and challenges of integrating cervical cancer screening and treatment into HIV services for women," with a focus on the efforts of Zambia.
A recent study published on the preprint server bioRxiv* in September 2020 looked to see if biting insects pose a risk for transmission of SARS-CoV-2 to humans or animals following a SARS-CoV-2 infected blood meal.
› Verified 5 days ago
| NPI Number | 1669712618 |
| Organization Name | OKC HEALTH FACILITIES LP |
| Doing Business As | WARR ACRES NURSING CENTER |
| Address | 6501 N Macarthur Blvd, Oklahoma City, OK 73132 |
| Phone Number | 405-721-5444 |
News Archive
UK scientists have developed a peptide that sticks to the protein that causes Parkinson's disease, stopping it from killing brain cells. The research highlights a potential new route for slowing the progress of this incurable disease.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Kai Ruggeri's research has one overriding objective: to improve the well-being of populations by confronting inequality.
In the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Janet Fleischman and Julia Nagel of CSIS discuss "the opportunities and challenges of integrating cervical cancer screening and treatment into HIV services for women," with a focus on the efforts of Zambia.
A recent study published on the preprint server bioRxiv* in September 2020 looked to see if biting insects pose a risk for transmission of SARS-CoV-2 to humans or animals following a SARS-CoV-2 infected blood meal.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
UK scientists have developed a peptide that sticks to the protein that causes Parkinson's disease, stopping it from killing brain cells. The research highlights a potential new route for slowing the progress of this incurable disease.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Kai Ruggeri's research has one overriding objective: to improve the well-being of populations by confronting inequality.
In the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Janet Fleischman and Julia Nagel of CSIS discuss "the opportunities and challenges of integrating cervical cancer screening and treatment into HIV services for women," with a focus on the efforts of Zambia.
A recent study published on the preprint server bioRxiv* in September 2020 looked to see if biting insects pose a risk for transmission of SARS-CoV-2 to humans or animals following a SARS-CoV-2 infected blood meal.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $50479 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.95 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 2.28 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 60.29 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.8 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.27 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.44 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.52 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 78.99 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.63 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 27.27 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.5 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 19.72 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.91 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.97 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.92 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 15.29 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 55.96 | 82.93 |
News Archive
UK scientists have developed a peptide that sticks to the protein that causes Parkinson's disease, stopping it from killing brain cells. The research highlights a potential new route for slowing the progress of this incurable disease.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Kai Ruggeri's research has one overriding objective: to improve the well-being of populations by confronting inequality.
In the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Janet Fleischman and Julia Nagel of CSIS discuss "the opportunities and challenges of integrating cervical cancer screening and treatment into HIV services for women," with a focus on the efforts of Zambia.
A recent study published on the preprint server bioRxiv* in September 2020 looked to see if biting insects pose a risk for transmission of SARS-CoV-2 to humans or animals following a SARS-CoV-2 infected blood meal.
› Verified 5 days ago
Brookwood Skilled Nursing And Therapy Location: 940 Southwest 84th Street, Oklahoma City, Oklahoma 73139 Phone: (405) 636-0626 | |
Heritage At Brandon Place Health & Rehabilitation Location: 13500 Brandon Place, Oklahoma City, Oklahoma 73142 Phone: (405) 720-0010 | |
Emerald Care Center Southwest Llc Location: 5600 South Walker, Oklahoma City, Oklahoma 73109 Phone: (405) 632-7771 | |
Capitol Hill Skilled Nursing And Therapy Location: 2400 Southwest 55th Street, Oklahoma City, Oklahoma 73119 Phone: (405) 681-5381 | |
Kingwood Skilled Nursing And Therapy Location: 1921 Northeast 21st Street, Oklahoma City, Oklahoma 73111 Phone: (405) 424-1449 | |
The Fountains At Canterbury Location: 1400 Northwest 122nd Street, Oklahoma City, Oklahoma 73114 Phone: (405) 751-3600 |